QuickGene-Auto12S/QuickGene-Auto24S are benchtop device for automated DNA/RNA isolation. It can isolate high-yield and high-purity of DNA/RNA due to the patented porous membrane. Specific reagent kits are pre-filled reagent strips. These strips are supplied in a sealed condition with required reagents for isolation in one strip to reduce the contamination risk. Key Features Specification Consumables *Warning […]
First end-to-end workflow for multi-species screening and identification BASINGSTOKE, England — Thermo Fisher Scientific announced the introduction of a new, complete next generation sequencing (NGS) workflow for multi-species screening and identification for food authenticity. This comes after Oxoid Ltd. (a part of Thermo Fisher Scientific) and SGS MOLECULAR, S.A. signed a global co-marketing and distribution agreement that […]
–CRISPR Therapeutics Gains Additional Rights to MaxCyte’s Cell Engineering Technology to Develop CRISPR/Cas9-Based Cell Therapies in Immuno-Oncology– ZUG, SWITZERLAND, CAMBRIDGE, MASS. and GAITHERSBURG, MD – CRISPR Therapeutics (NASDAQ:CRSP) and MaxCyte today announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation® […]
Company creates U.S. subsidiary and adds Dr. Jeffrey Jeddeloh as VP of Business Development, Commercial Strategy, Dr. Stephen Macevicz as VP of IP and Dr. Christine Peponnet as VP of Technology Development. PARIS and CAMBRIDGE, Mass. – DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced the creation of DNA Script […]
Project to focus on genetic testing technologies to expand access to personalized medicine CHICAGO — Blue Cross Blue Shield Association (BCBSA) and Illumina, Inc. today announced an important partnership to determine the availability and clinical understanding of DNA sequencing technologies, genetic testing and precision medicine across the country in an effort to provide patients with expanded access […]
Dolomite Bio, a leading provider of single cell technology, today launched a high throughput single nuclei RNA sequencing (sNuc-Seq) protocol for its Nadia Instrument. This latest addition to the Nadia application portfolio enables researchers to cost-effectively profile both complex and archived tissues with the goal of accelerating disease and drug discovery research in areas such […]
Project to focus on genetic testing technologies to expand access to personalized medicine Blue Cross Blue Shield Association (BCBSA) and Illumina, Inc. today announced an important partnership to determine the availability and clinical understanding of DNA sequencing technologies, genetic testing and precision medicine across the country in an effort to provide patients with expanded access […]
NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a new gene expression panel for the molecular characterization of CAR-T cells in research, development and manufacturing. The nCounter® CAR-T Characterization Panel was created in collaboration with eight leading centers in the field of CAR-T […]
Following successful European rollout, more customers to benefit from enhanced local sales and support services Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it has expanded its direct sales of Cytocell Fluorescence In Situ Hybridisation (FISH) products to include the Asia-Pacific (APAC) region. OGT will provide customers in Singapore, Malaysia, Vietnam, Australia, and New Zealand with enhanced local […]
Large-Scale Production of Linear DNA Shows the Best Lot-To-Lot Reproducibility and Sequence Accuracy for Kits Targeting Autoimmunity and Infectious Diseases STONY BROOK, NY. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”), the leader in large-scale PCR-based DNA manufacturing, announced today that LineaRx, Inc. (“LineaRx” or the “Company”) has been providing linear DNA to Technogenetics (Shanghai Kehua Bio-Engineering […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
